Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries is currently trading at Rs. 570.20, up by 6.70 points or 1.19% from its previous closing of Rs. 563.50 on the BSE.

The scrip opened at Rs. 566.00 and has touched a high and low of Rs. 573.30 and Rs. 566.00 respectively. So far 33446 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 653.10 on 03-Mar-2014 and a 52 week low of Rs. 405.50 on 01-Apr-2013.

Last one week high and low of the scrip stood at Rs. 587.95 and Rs. 556.50 respectively. The current market cap of the company is Rs. 118387.73 crore.

The promoters holding in the company stood at 63.65% while Institutions and Non-Institutions held 28.23% and 8.11% respectively.

Sun Pharmaceutical is planning to purchase Standard Chartered Tower located at Goregaon suburb in Mumbai from Standard Chartered Bank for Rs 280 crore. Standard Chartered Tower has total built-up space of 2.20 lakh sq ft, with ground plus six upper floors including two basements. The deal is valued at Rs 12,700 per sq ft on a built-up space basis.

Both the parties have already entered into an agreement for transfer of the property .The deal will be concluded in the next few weeks.

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.